首頁
1
最新消息
2
活動
3
CRUSABIO 研發出變種病毒Omicron的試劑,歡迎來電預訂!!!!!4
精磊生技實業有限公司 台北市中山區德惠街7-1號810室
On November 11, 2021, Matthias Kettwig, Gogentine University Medical Center, Germany, and his team , published a paper titled "Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy" on Nature Communications, which suggested that RNaseT2-/- mice can be used to study central nervous system damage associated with RnaseT2 defects. https://www.genlabbiotech.com/hot_412970.html [Cloud-clone] Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy 2022-01-10 2023-01-10
精磊生技實業有限公司 台北市中山區德惠街7-1號810室 https://www.genlabbiotech.com/hot_412970.html
精磊生技實業有限公司 台北市中山區德惠街7-1號810室 https://www.genlabbiotech.com/hot_412970.html
https://schema.org/EventMovedOnline https://schema.org/OfflineEventAttendanceMode
2022-01-10 http://schema.org/InStock TWD 0 https://www.genlabbiotech.com/hot_412970.html

e8158c84e1470f2c882ca676ef084030.png

On 26 November 2021, WHO designated the variant B.1.1.529 -the newest COVID-19 "variant of concern" , named Omicron.

Why are scientists worried about it?

Omicron (B.1.1.529) was first detected in Southern Africa. Omicron's rapid rise in South Africa is what worries researchers most. Cases have also been reported in Botswana, but also in Israel, Belgium, the U.K., even Hong Kong. So far, the virus has been detected in more than 30 countries and at least 9 states. The COVID-19 Omicron variant has already made its way across the globe.

What scientists know so far?

The B.1.1.529 variant carries more than 30 mutations in the Spike protein, which is has an unprecedented number of mutations compared to Delta. It's critically important to understand whether these mutations allow the Omicron variant to escape from neutralizing antibodies. It is not yet clear about the Transmissibility and Severity of disease.

Does Omicron boast faster transmission and stronger resistance to established immunity? Omicron is a big unknown.

7d5789108031783ae7810dcc0f7c82d9.png

Omicron (B.1.1.529) Reagents: CUSABIO are Starting to Take Pre-Orders!

At present, epidemiologists, Laboratorians and researchers worldwide are conducting studies to better understand many aspects of Omicron. To support the study of Omicron variants, CUSABIO is developing Omicron Variants related products. We're starting to take Pre-orders now. Pre-orders will allow you to guarantee immediate shipment on release. Here is the collection for the most popular SARS-CoV-2 Omicron products.

56f54f8c9b8cc37cacbf639744ce901a.jpg

As the COVID-19 pandemic evolves, we are with you during these turbulent times. CUSABIO appreciates the critical role that you and our products play in research efforts to further scientific innovation and discovery. We know that many scientists are diligently pursuing their research throughout the pandemic. Our customer service and technical support teams are equipped to remain available to help with your research needs and answer any questions.

上一個 回列表 下一個